v3.26.1
Subsequent Events (Details) - USD ($)
May 15, 2026
May 12, 2026
May 06, 2026
Apr. 10, 2026
Apr. 01, 2026
Mar. 31, 2026
Dec. 31, 2025
Subsequent Events [Line Items]              
Stockholders’ equity           $ (33,276,889) $ 5,609,704
Reverse stock split 1-for-27            
Subsequent Event [Member]              
Subsequent Events [Line Items]              
Stockholders’ equity         $ 3,953,682    
Consecutive business days     30 years        
Minimum bid price per share (in Dollars per share)     $ 1        
Principal amount       $ 1,250,000      
Aggregate purchase price       $ 1,000,000      
New issues (in Shares)       250,000      
Percentage of interest rate       10.00%      
Percentage of aggregate gross proceeds from ATM or equity line of credit       100.00%      
Percentage of redemption price of outstanding amount redeemed       120.00%      
Warrant exercised (in Shares)         110,737    
warrants shares of common stock. (in Shares)         110,737    
Ignite Proteomics, LLC [Member] | Subsequent Event [Member]              
Subsequent Events [Line Items]              
Pre-money equity valuation   $ 150,000,000          
Series A-1 Convertible Preferred Stock Conversions [Member] | Subsequent Event [Member]              
Subsequent Events [Line Items]              
Number of preferred stock shares converted (in Shares)         2,353    
Value of preferred stock shares converted         $ 666,382